Is Ginkgo Bioworks Stock a Good Buy?
Biotech innovator Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) has had better…
Buy
58
PGNY Quote, Financials, Valuation and Earnings
Last price:
$21.50
Seasonality move
:
6.53%
Day range:
$21.92 - $22.70
52-week range:
$13.39 - $30.42
Dividend yield:
0%
P/E ratio:
39.12x
P/S ratio:
1.73x
P/B ratio:
4.09x
Volume:
1.2M
Avg. volume:
1.2M
1-year change:
-19.06%
Market cap:
$1.9B
Revenue:
$1.2B
EPS (TTM):
$0.57
Earnings Data
Next earnings date for PGNY
Aug 06
2025
Most recent earnings per share
$0.17
Missed by $0.28
(May 9/2025)
Consensus Estimate
$0.45
(May 9/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
PGNY Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 08/06/2025 | Q2 | $316.3M | -- | -- | $0.41 | -- |
| 05/09/2025 | Q1 | $307.8M | $324M | $0.17 | $0.45 | -$0.28 |
| 02/27/2025 | Q4 | $277.3M | $298.4M | $0.12 | $0.37 | -$0.25 |
| 11/12/2024 | Q3 | $297.4M | $286.6M | $0.11 | $0.37 | -$0.26 |
| 08/06/2024 | Q2 | $304.8M | $304.1M | $0.17 | $0.40 | -$0.23 |
| 05/09/2024 | Q1 | $289.4M | $278.1M | $0.17 | $0.35 | -$0.18 |
| 02/27/2024 | Q4 | $274.1M | $269.9M | $0.13 | $0.11 | $0.02 |
| 11/07/2023 | Q3 | -- | -- | $0.16 | $0.11 | $0.05 |
| 08/03/2023 | Q2 | -- | -- | $0.15 | $0.10 | $0.05 |
| 05/08/2023 | Q1 | -- | -- | $0.18 | $0.08 | $0.10 |
| 02/27/2023 | Q4 | -- | -- | $0.03 | $0.02 | $0.01 |
| 11/03/2022 | Q3 | -- | -- | $0.13 | $0.03 | $0.10 |
| 08/04/2022 | Q2 | -- | -- | $0.09 | $0.02 | $0.07 |
| 05/05/2022 | Q1 | -- | -- | $0.05 | -$0.02 | $0.07 |
| 02/28/2022 | Q4 | -- | -- | $0.15 | $0.04 | $0.11 |
| 11/04/2021 | Q3 | -- | -- | $0.17 | $0.06 | $0.11 |
| 08/05/2021 | Q2 | -- | -- | $0.19 | $0.09 | $0.10 |
| 05/06/2021 | Q1 | -- | -- | $0.15 | $0.09 | $0.06 |
| 02/24/2021 | Q4 | -- | -- | $0.39 | $0.07 | $0.32 |
| 11/05/2020 | Q3 | -- | -- | $0.05 | $0.06 | -$0.01 |
| 08/05/2020 | Q2 | -- | -- | -$0.02 | -$0.02 | $0.00 |
| 05/12/2020 | Q1 | -- | -- | $0.04 | $0.02 | $0.02 |
| 03/05/2020 | Q4 | -- | -- | -$0.07 | $0.02 | -$0.09 |
| 12/04/2019 | Q3 | -- | -- | -$0.10 | $0.02 | -$0.12 |
Progyny Earnings Questions
-
How Much did Progyny Generate in Revenue Last Quarter?
Progyny reported $324M worth of top line sales in its most recent quarter.
-
Did Progyny Beat Earnings Last Quarter?
Progyny announced earnings per share of $0.17 which represents a miss of analyst forecast a $0.45 per share.
-
Is Progyny Profitable?
Progyny reported $75.8M that represents $0.85 per share over the last quarter.
-
What is the Analyst Consensus for Progyny EPS Next Year?
Progyny's earnings are forecast to grow from $0.57 per share to $1.57 per share next year representing an increase of 181.75%.
-
When is Progyny's Earnings Date?
Progyny's next earnings date is August 6, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Mobileye Might Be Wall Street’s Next Big Surprise
The trend to automate vehicles started long ago when adding…
Why Is Rigetti Stock Going Up?
Quantum computing firm Rigetti Computing (NASDAQ:RGTI) has been one of…
Stock Ideas
Buy
67
Is MSFT Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 38x
Buy
71
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 46x
Sell
46
Is AAPL Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 35x
Alerts
Buy
81
SMLR alert for May 19
Semler Scientific [SMLR] is up 5.85% over the past day.
Sell
25
GLOB alert for May 19
Globant SA [GLOB] is up 4.02% over the past day.
Buy
94
HIMS alert for May 19
Hims & Hers Health [HIMS] is down 3.57% over the past day.
